课题基金 / 基金详情

Pilot Projects Program

Pilot Projects Program
试点项目计划
批准号:
10472653
负责人:
Celso Enrique Gomez-Sanchez
金额:
$76.25万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-08-18 至 2026-07-31

项目摘要

项目成果

Celso Enrique Gomez-Sanchez的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要-试点项目实现MCCTR目标的核心是 扩大密西西比临床、转化和社区研究的能力是其试点项目计划 (购买力平价)。PPP支持临床,转化和人口研究项目,这些项目将成为 有竞争力的校外资助申请。在第一阶段,向早期发展提供支助的主要考虑因素 阶段调查包括(1)吸引校外资金的可能性,(2)通往 申请人的独立研究生涯,以及(3)研究计划将导致 改善肥胖症或肥胖相关疾病的管理。其他考虑包括支持 种族和性别多样性,促进多学科和多机构的研究项目, 在MCCTR伙伴机构之间分配资源。在第二阶段,公私伙伴关系举措的广度 将以多种方式扩展。首先,我们的试点项目奖励的重点将扩大到包括健康 如肥胖症、糖尿病、心血管和肾脏疾病、癌症、传染病和 孕产妇保健,所有这些疾病在农村和经济贫困地区都很普遍, 我们的国家。二是有资格参加公开征集的高等学校数量 申请将扩大到包括Tougaloo学院,南密西西比大学, 密西西比医学中心,以及我们的新成员,密西西比州立大学和密西西比大学 在牛津第三,一个新的资助计划,提供高达5,000美元的种子资金,以支持多机构 合作和初步数据收集,以制定随后的PPP提案, 将在其他地方推出。公私营界别合作计划每年会接受两次拨款申请, 在密西西比州内的优先健康领域开展由州政府发起的临床和转化研究,包括 社区参与的研究,解决密西西比的健康差距和获得保健问题,与 预计每年资助多达7个试点项目。种子赠款计划的申请将征求 每年四次,通过快速申请和审查程序。对于所有方案,研究解决 将优先重视健康差距和医疗服务不足的人口,重点是执行。 公私伙伴关系及其相关计划将支持多机构和多学科的合作 来自不同学术和文化背景的强大研究人员之间的研究。总的来说,这种方法 将导致一个基础广泛的,全州范围的研究平台,有能力改善健康结果, 解决密西西比州的健康差距。
英文摘要
PROJECT SUMMARY- PILOT PROJECTS PROGRAM. Central to realizing the MCCTR's purpose of expanding Mississippi's capacity for clinical, translational, and community research is its Pilot Projects Program (PPP). The PPP supports clinical, translational, and population research projects that will become the basis for competitive extramural funding applications. During Phase I, key considerations in awarding support to early stage investigators included the (1) likelihood of attracting extramural funding, (2) evidence of a path toward an independent research career for the applicant, and (3) probability that the research program would lead to improved management of obesity or obesity-related diseases. Additional considerations included support for ethnic and gender diversity, promoting multi-disciplinary and multi-institutional research projects, and equitable distribution of resources across the MCCTR partner institutions. During Phase II, the breadth of PPP's initiatives will be expanded in several ways. First, the focus of our pilot project awards will be expanded to include health conditions such as obesity, diabetes, cardiovascular and renal disease, cancer, infectious diseases, and maternal health, all of which are disproportionally prevalent in rural and economically disadvantaged areas of our state. Second, the number of institutions of higher learning eligible to participate in open solicitation for applications will be expanded to include Tougaloo College, University of Southern Mississippi, the University of Mississippi Medical Center, and our new members, Mississippi State University and the University of Mississippi in Oxford. Third, a new funding program that provides up to $5,000 in seed money to support multi-institutional collaboration and preliminary data collection for development of a subsequent proposal to the PPP and elsewhere will be introduced. The PPP will solicit applications for funding two times per year to support investigator-initiated clinical and translational research of priority health areas within Mississippi, including community-engaged research addressing Mississippi's health disparities and access-to-care issues, with the expectation of funding up to seven pilot projects per year. Applications for the seed grant program will be solicited four times per year through an expedited application and review process. For all programs, studies addressing health disparities and medically underserved populations with an emphasis on implementation will be prioritized. The PPP and its related programs will lead to support for multi-institutional and multi-disciplinary collaborative research among strong investigators from diverse academic and cultural backgrounds. Overall, this approach will lead to a broad-based, state-wide research platform that has the capacity to improve health outcomes and address health disparities across Mississippi.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Mineralocorticoid Receptor Action
Regulation of Mineralocorticoid Receptor Action
Regulation of Mineralocorticoid Receptor Action
Regulation of Mineralocorticoid Receptor Action
海外基金